1. Home/
  2. Compounds/
  3. tretinoin:navitoclax (4:1 mol/mol)

tretinoin:navitoclax (4:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tretinoin:navitoclax (4:1 mol/mol)
PharmacoGx tretinoin:navitoclax (4:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tretinoin:navitoclax (4:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA EMC6 CTRPv2 pan-cancer AAC -0.19 6e-08
mRNA GRIK5 CTRPv2 pan-cancer AAC 0.2 7e-08
mRNA MYT1L CTRPv2 pan-cancer AAC 0.21 7e-08
mRNA ITGAL CTRPv2 pan-cancer AAC 0.21 7e-08
mRNA PTPN7 CTRPv2 pan-cancer AAC 0.26 8e-08
mRNA LST1 CTRPv2 pan-cancer AAC 0.2 8e-08
mRNA CBX2 CTRPv2 pan-cancer AAC 0.21 8e-08
mRNA FAM57B CTRPv2 pan-cancer AAC 0.21 9e-08
mRNA PPP1R27 CTRPv2 pan-cancer AAC 0.18 9e-08
mRNA ZNF397 CTRPv2 pan-cancer AAC 0.2 1e-07
Download CSV